Pharmacogenomics and colorectal cancer.
Lenz
H-J
HJ
Division of Medical Oncology, University of Southern California/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, USA.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D004260:DNA Repair; D005472:Fluorouracil / Q000008:administration & dosage; D020869:Gene Expression Profiling; D018095:Germ-Line Mutation; D006801:Humans; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin; D010597:Pharmacogenetics / Q000639:trends*; D011110:Polymorphism, Genetic; D011379:Prognosis; D013940:Thymidylate Synthase / Q000235:genetics / Q000494:pharmacology
D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D013940:Thymidylate Synthase; D005472:Fluorouracil